Company Filing History:
1 out of 1 
1 out of 3,566 
1 out of 4 Years Active: 2021-2022
Title: Enhong Jiang: Innovator in Cancer Treatment
Introduction
Enhong Jiang is a notable inventor based in Liaoning, China. He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a total of 2 patents, Jiang's work focuses on developing pharmaceutical compositions that target various types of tumors.
Latest Patents
One of Jiang's latest patents is titled "Use of isovalerylspiramycins as anti-cancer agents to inhibit metastasis." This invention describes a pharmaceutical composition that includes 4″-O-isovalerylspiramycin I, II, and III, which counters tumorigenesis and reduces or prevents metastasis by inhibiting selenoprotein H. This mechanism triggers genomic instability and cell-cycle arrest in cancer cells. Another significant patent is "Use of carrimycin and pharmaceutically acceptable salts of carrimycin in manufacturing medicament for treating and/or preventing tumor." This patent outlines the use of carrimycin and its salts for preparing a medicament effective against various tumors, including breast cancer, liver cancer, and lung cancer, among others. The invention demonstrates promising curative effects, particularly against human breast cancer cells and other cancer types.
Career Highlights
Throughout his career, Enhong Jiang has worked with reputable organizations, including Asclea Corporation and the National Institutes of Health, which is a component of the US Department of Health & Human Services. His experience in these institutions has contributed to his expertise in pharmaceutical research and development.
Collaborations
Jiang has collaborated with notable colleagues, including Zhengping Zhuang and Jing Cui, enhancing the impact of his research through teamwork and shared knowledge.
Conclusion
Enhong Jiang's innovative work in cancer treatment showcases his dedication to advancing medical science. His patents reflect a commitment to developing effective therapies for various cancers, making a significant impact in the field.